Literature DB >> 9840583

The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period.

N Furusyo1, J Hayashi, Y Sawayama, Y Kawakami, Y Kishihara, S Kashiwagi.   

Abstract

Serial changes in hepatitis A virus (HAV) and B virus (HBV) markers were determined from 1970 to 1996 in healthy Japanese residents of a rural area of Okinawa, Japan. All 190 serum samples taken in 1970, 791 in 1980, 708 in 1988, and 523 in 1996 from residents 0 to more than 60 years of age were tested for antibody to HAV (anti-HAV), antibody to hepatitis B core antigen (anti-HBc), and hepatitis B surface antigen (HBsAg). The age-adjusted prevalences of anti-HAV and anti-HBc decreased significantly from 83.9% and 74.9%, respectively, in 1970 to 39.7% and 36.6%, respectively, in 1996. In residents < or = 29 years of age, the prevalences of anti-HAV and anti-HBc decreased significantly from 65.3% and 83.8%, respectively, in 1970 to 0.7% and 8.2%, respectively, in 1996. The age-adjusted HBsAg prevalence decreased significantly from 8.2% in 1980 to 4.1% in 1988. These results indicate that exposure to HAV and HBV infections among Okinawa residents less than 29 years of age is decreasing, probably because of improvements in socioeconomic conditions since 1970. Infection with HBV may be eliminated there in the near future.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840583     DOI: 10.4269/ajtmh.1998.59.693

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

Review 1.  Considerations of HAV vaccine in India.

Authors:  P Mathur; N K Arora
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

2.  Hepatitis B and C viral infections among blood donors from rural Ghana.

Authors:  B Nkrumah; M Owusu; H O Frempong; P Averu
Journal:  Ghana Med J       Date:  2011-09

3.  Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.

Authors:  J Mossong; L Putz; S Patiny; F Schneider
Journal:  Epidemiol Infect       Date:  2006-01-25       Impact factor: 2.451

4.  Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients.

Authors:  Masayuki Murata; Norihiro Furusyo; Mami Unno; Eiichi Ogawa; Kazuhiro Toyoda; Hiroaki Taniai; Hachiro Ohnishi; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

5.  Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.

Authors:  Motohiro Shimizu; Norihiro Furusyo; Hiroaki Ikezaki; Eiichi Ogawa; Takeo Hayashi; Takeshi Ihara; Yuji Harada; Kazuhiro Toyoda; Masayuki Murata; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

6.  Clinical features of polyarteritis nodosa in Korea.

Authors:  Young Deok Bae; Hyo Jin Choi; Jung Chan Lee; Jeong Jin Park; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

7.  Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana.

Authors:  Bernard Nkrumah; Michael Owusu; Paul Averu
Journal:  BMC Res Notes       Date:  2011-12-12

8.  Seroepidemiology of HBV infection in South Korea, 1995 through 1999.

Authors:  M K Jang; J Y Lee; J H Lee; Y B Kim; H Y Kim; M S Lee; C K Park; J Y Yoo
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

9.  Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.

Authors:  Soyoung Lee; Han Wool Kim; Kyung Hyo Kim
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.